Revance to Participate in Upcoming Investor Conferences
Cowen 44th Annual Healthcare Conference
Chief Executive Officer,
Chief Executive Officer,
Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company's website at www.revance.com. The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.
About Revance
Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Revance’s portfolio includes DAXXIFY (daxibotulinumtoxinA-lanm) for injection and the RHA® Collection of dermal fillers in the
Revance is headquartered in
“Revance”, the Revance logo, and DAXXIFY are registered trademarks of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240221269040/en/
Investors
jessica.serra@revance.com
or
laurence@gilmartinir.com
Media
cathryn.castaldo@revance.com
Source: